114 related articles for article (PubMed ID: 3952023)
1. Correlation of pretreatment plasma levels of estradiol and sex-hormone-binding globulin-binding capacity with clinical stage and survival of patients with prostatic cancer.
Haapiainen R; Rannikko S; Adlercreutz H; Alfthan O
Prostate; 1986; 8(2):127-37. PubMed ID: 3952023
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment hormone levels in prostatic cancer.
Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
Scand J Urol Nephrol Suppl; 1988; 110():137-43. PubMed ID: 3187401
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment plasma levels of testosterone and sex hormone binding globulin binding capacity in relation to clinical staging and survival in prostatic cancer patients.
Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
Prostate; 1988; 12(4):325-32. PubMed ID: 3393494
[TBL] [Abstract][Full Text] [Related]
4. Effects of orchidectomy and different modes of high dose estrogen treatment on circulating "free" and total 1,25-dihydroxyvitamin D in patients with prostatic cancer.
Hagenfeldt Y; Carlström K; Berlin T; Stege R
J Steroid Biochem Mol Biol; 1991 Aug; 39(2):155-9. PubMed ID: 1888674
[TBL] [Abstract][Full Text] [Related]
5. Orchiectomy, estrogen therapy and radiotherapy in locally advanced (T3-4 M0) prostatic cancer.
Aro J; Haapiainen R; Kajanti M; Rannikko S; Alfthan O
Scand J Urol Nephrol Suppl; 1988; 110():103-7. PubMed ID: 3187397
[TBL] [Abstract][Full Text] [Related]
6. Single drug polyestradiol phosphate therapy in prostatic cancer.
Stege R; Carlström K; Collste L; Eriksson A; Henriksson P; Pousette A
Am J Clin Oncol; 1988; 11 Suppl 2():S101-3. PubMed ID: 3242384
[TBL] [Abstract][Full Text] [Related]
7. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.
Tomić R
Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040
[TBL] [Abstract][Full Text] [Related]
8. Total estradiol, free estradiol, sex hormone-binding globulin, and the fraction of estradiol bound to sex hormone-binding globulin in human follicular fluid.
Ben-Rafael Z; Mastroianni L; Meloni F; Lee MS; Flickinger GL
J Clin Endocrinol Metab; 1986 Nov; 63(5):1106-11. PubMed ID: 3093520
[TBL] [Abstract][Full Text] [Related]
9. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer.
Rannikko S; Adlercreutz H
Prostate; 1983; 4(3):223-9. PubMed ID: 6189106
[TBL] [Abstract][Full Text] [Related]
10. Comparison of primary orchiectomy with oestrogen therapy in advanced prostatic cancer. A 2-year follow-up report of a national, prospective prostatic cancer study.
Haapiainen R; Rannikko S; Alfthan O
Br J Urol; 1986 Oct; 58(5):528-33. PubMed ID: 3779355
[TBL] [Abstract][Full Text] [Related]
11. Early results of the Finnish Multicentre Study of Prostatic Cancer (Finnprostate).
Haapiainen R; Rannikko S; Ruutu M; Ala-Opas M; Aro J; Ervasti J; Hansson E; Hurme K; Juusela H; Mäkinen J
Ann Chir Gynaecol; 1985; 74(6):277-83. PubMed ID: 4096480
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population.
Aro J
Prostate; 1991; 18(2):131-7. PubMed ID: 2006119
[TBL] [Abstract][Full Text] [Related]
13. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
[TBL] [Abstract][Full Text] [Related]
14. Comparison of endocrine and radiation therapy in locally advanced prostatic cancer.
Aro J; Haapiainen R; Kajanti M; Rannikko S; Alfthan O
Eur Urol; 1988; 15(3-4):182-6. PubMed ID: 3063541
[TBL] [Abstract][Full Text] [Related]
15. Changes in sex hormone-binding globulin binding capacity and percent free estradiol during development in the female rhesus monkey (Macaca mulatta): relation to the metabolic clearance rate of estradiol.
Hotchkiss J
J Clin Endocrinol Metab; 1985 Apr; 60(4):786-92. PubMed ID: 4038716
[TBL] [Abstract][Full Text] [Related]
16. Primary orchiectomy versus estrogen therapy in advanced prostatic cancer--a randomized study: results after 7 to 10 years of followup.
Johansson JE; Andersson SO; Holmberg L; Bergström R
J Urol; 1991 Mar; 145(3):519-22; discussion 522-3. PubMed ID: 1997702
[TBL] [Abstract][Full Text] [Related]
17. Prediction of cardiovascular complications in patients with prostatic cancer treated with estrogen.
Henriksson P; Johansson SE
Am J Epidemiol; 1987 Jun; 125(6):970-8. PubMed ID: 3578255
[TBL] [Abstract][Full Text] [Related]
18. Effect of estrogens on prolactin secretion in transsexual subjects.
Goh HH; Ratnam SS
Arch Sex Behav; 1990 Oct; 19(5):507-16. PubMed ID: 2260915
[TBL] [Abstract][Full Text] [Related]
19. Validity of the calculation of non-sex hormone-binding globulin-bound estradiol from total testosterone, total estradiol and sex hormone-binding globulin concentrations in human serum.
Belgorosky A; Escobar ME; Rivarola MA
J Steroid Biochem; 1987 Oct; 28(4):429-32. PubMed ID: 3669662
[TBL] [Abstract][Full Text] [Related]
20. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
